AVENUE THERAPEUTICS, INC. (ATXI) › Operating IncomeAVENUE THERAPEUTICS, INC. (ATXI) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2016: -$2.38M2017: -$11.42M2018: -$21.82M2019: -$26.27M2020: -$5.21M2021: -$3.74M2022: -$8.04M2023: -$14.54M2024: -$11.28M2025: -$3.08M-$3.08M2016Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$3.08M+72.7%2024-$11.28M+22.4%2023-$14.54M-80.8%2022-$8.04M-115.2%2021-$3.74M+28.3%2020-$5.21M+80.2%2019-$26.27M-20.4%2018-$21.82M-91.0%2017-$11.42M-380.5%2016-$2.38M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share